Biologic Imaging Reagents Market

Biologic Imaging Reagents Market by Classes (Nuclear Reagents, Optical Reagents, and Contrast Reagents [X-ray, MRI Reagents, CT Reagents, and Ultrasound Reagents]) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021-2028

  • Report ID: HC-2700
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 40
  • No. Of Pages: 183
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global biologic imaging reagents market size is estimated to register a significant CAGR during the forecast period, 2021-2028. The growth of the biologic imaging reagents market is attributed to the wide prevalence of cardiovascular disorders, malignancy, cancer, and neurological complications among the population base across the globe.

Biologic Imaging Reagents Market key takeaways

The agents and substances that are used in various imaging modalities for the superior visualization of internal organs of the body for the diagnosis of several diseases are known as biologic imaging reagents. The biological processes are detected at a molecular level using such reagents. Owing to its certain advantages, the biologic imaging reagents play a vital role in the field of science, pharmaceuticals, biotechnology, and medical industries. Moreover, it is widely used by medical practitioners & researchers for research-based or diagnosis purposes. The diagnostic information can be obtained for the detection of oncology, cardiovascular, and neurology disorders, which can render further help for the treatment of these diseases.

As per the fact sheet by Globocan 2020, approximately 19,292,789 new cancer cases were diagnosed along with 9,958,133 deaths caused by cancer worldwide. Another report by the International Agency for Research on Cancer (IARC) states that globally the total sum of cancer cases is expected to reach 27.5 million along with 16.3 million deaths caused due to cancer. According to the reports by the World Health Organization (WHO), cancer is the second leading cause of death among people next to cardiovascular diseases. Hence, the aforementioned factors are helping the market growth.

Market Trends, Drivers, Restraints, and Opportunities

  • Growing level of awareness among the patients and increasing number of diagnostic procedures are anticipated to boost the market growth in the coming years.
  • Due to the introduction of digital systems, the demand for diagnostic imaging systems including X-ray and MRI devices has increased rapidly. This is expected to drive the market expansion during the forecast period.
  • Technological advancements made in the field of nuclear imaging for diagnosis purpose is anticipated to drive the market expansion in the coming years.
  • Biologic imaging reagents have a smaller shelf-life, high cost, and need massive funding. These factors are key challenges that can restrain the market expansion.
  • Increasing research & development initiatives in order to enhance the imaging techniques is projected to create lucrative opportunities for the market during the forecast period.

Scope of the Report

The report on the global biologic imaging reagents market includes an assessment of the market, trends, and segments. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Biologic Imaging Reagents Market – Global Industry Analysis, Growth, Share, Size, Trends, And Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Classes (Nuclear Reagents, Optical Reagents, and Contrast Reagents [X-ray, MRI Reagents, CT Reagents, and Ultrasound Reagents])

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Siemens Healthcare; Bayer Healthcare AG; Beckman Coulter Inc.; Cardinal Health; Philips Healthcare; Johnson and Johnson; and Bracco Imaging

Market Segment Insights

Contrast reagents segment is anticipated to account for a major market share

On the basis of classes, the global biologic imaging reagents market is divided into nuclear reagents, optical reagents, and contrast reagents. The contrast reagents segment is further divided into X-ray, MRI reagents, CT reagents, and ultrasound reagents. The contrast reagents segment is anticipated to account for a major market share during the forecast period owing to the increasing popularity of these devices and their rising usage along with the increasing demand for home healthcare and point of care diagnostics (POCs).

Biologic Imaging Reagents Market by classes

Asia Pacific market is expected to expand at a high rate

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the projected period attribute to awareness among patient, high per capita healthcare expenditure, and the availability of sophisticated healthcare infrastructure in the region. On the other hand, the Asia Pacific market is expected to expand at a high growth rate in the coming years owing to the presence of medical needs that are highly unmet and growing improvement in the healthcare infrastructure.

Biologic Imaging Reagents Market by regions

Segments

The global biologic imaging reagents market has been segmented on the basis of

Classes

  • Nuclear Reagents
  • Optical Reagents
  • Contrast Reagents
    • X-ray
    • MRI Reagents
    • CT Reagents
    • Ultrasound Reagents

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Siemens Healthcare
  • Bayer Healthcare AG
  • Beckman Coulter Inc.
  • Cardinal Health
  • Philips Healthcare
  • Johnson and Johnson
  • Bracco Imaging

Competitive Landscape

Key players competing in the global biologic imaging reagents market are Siemens Healthcare; Bayer Healthcare AG; Beckman Coulter Inc.; Cardinal Health; Philips Healthcare; Johnson and Johnson; and Bracco Imaging. Many of these players have adopted business strategies such as the launch of new products, the advancement of technologies, partnerships, mergers, and production capacity expansion in order to increase their consumer base and expand their market position globally.

Biologic Imaging Reagents Market by key players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Biologic Imaging Reagents Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Biologic Imaging Reagents Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Biologic Imaging Reagents Market - Supply Chain
  4.5. Global Biologic Imaging Reagents Market Forecast
     4.5.1. Biologic Imaging Reagents Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Biologic Imaging Reagents Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Biologic Imaging Reagents Market Absolute $ Opportunity
5. Global Biologic Imaging Reagents Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Biologic Imaging Reagents Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Biologic Imaging Reagents Demand Share Forecast, 2019-2026
6. North America Biologic Imaging Reagents Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Biologic Imaging Reagents Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Biologic Imaging Reagents Demand Share Forecast, 2019-2026
7. Latin America Biologic Imaging Reagents Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Biologic Imaging Reagents Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Biologic Imaging Reagents Demand Share Forecast, 2019-2026
8. Europe Biologic Imaging Reagents Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Biologic Imaging Reagents Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Biologic Imaging Reagents Demand Share Forecast, 2019-2026
9. Asia Pacific Biologic Imaging Reagents Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Biologic Imaging Reagents Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Biologic Imaging Reagents Demand Share Forecast, 2019-2026
10. Middle East & Africa Biologic Imaging Reagents Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Biologic Imaging Reagents Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Biologic Imaging Reagents Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Biologic Imaging Reagents Market: Market Share Analysis
  11.2. Biologic Imaging Reagents Distributors and Customers
  11.3. Biologic Imaging Reagents Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Siemens Healthcare
     11.4.2. Bayer Healthcare AG
     11.4.3. Beckman Coulter Inc.
     11.4.4. Cardinal Health
     11.4.5. Philips Healthcare
     11.4.6. Johnson and Johnson
     11.4.7. Bracco Imaging

The global biologic imaging reagents market has been segmented on the basis of

Classes

  • Nuclear Reagents
  • Optical Reagents
  • Contrast Reagents
    • X-ray
    • MRI Reagents
    • CT Reagents
    • Ultrasound Reagents

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Siemens Healthcare
  • Bayer Healthcare AG
  • Beckman Coulter Inc.
  • Cardinal Health
  • Philips Healthcare
  • Johnson and Johnson
  • Bracco Imaging

Key players competing in the global biologic imaging reagents market are Siemens Healthcare; Bayer Healthcare AG; Beckman Coulter Inc.; Cardinal Health; Philips Healthcare; Johnson and Johnson; and Bracco Imaging. Many of these players have adopted business strategies such as the launch of new products, the advancement of technologies, partnerships, mergers, and production capacity expansion in order to increase their consumer base and expand their market position globally.

Biologic Imaging Reagents Market by key players

Buy Report